Introduction
============

Cancer is a leading cause of mortality worldwide and includes numerous diseases characterized by the uncontrolled proliferation of anaplastic cells, which are able to invade surrounding tissues and metastasize to other organs ([@b1-etm-0-0-5191]). Many currently available antitumor drugs have been demonstrated to cause intolerable side effects and complications; for instance, doxorubicin may induce severe cardiac toxicity ([@b2-etm-0-0-5191]). Therefore, it is important to identify natural, less toxic and effective products to prevent and treat cancer. For a number of years, humans have benefited from green plants as a source of pharmacological agents and herbal remedies ([@b3-etm-0-0-5191],[@b4-etm-0-0-5191]). For example, mushrooms have attracted attention as a traditional food and medicine for a long time. The polysaccharides of mushrooms were proven to be an effective ingredient for the treatment of diseases such as lung cancer and colorectal carcinoma ([@b5-etm-0-0-5191]). In addition to mushroom polysaccharides, other polysaccharides isolated from natural materials have also been demonstrated to prevent ailments including gastroenteric dysfunction, diarrhea and cancer ([@b6-etm-0-0-5191],[@b7-etm-0-0-5191]).

*Phellinus igniarius* (PI), one of the most famous traditional Chinese medicines, is classified into *Hymenochaetaceae Basidiomycete*, and is widely used in Asia ([@b8-etm-0-0-5191],[@b9-etm-0-0-5191]). PI polysaccharides (PIP), the aqueous extraction of PI, have been demonstrated to have an antitumor bioactivity ([@b10-etm-0-0-5191]). Previous research into the antitumor mechanisms have focused on the direct inhibition of cancer cells ([@b11-etm-0-0-5191],[@b12-etm-0-0-5191]). However, polysaccharides have attracted more attention due to their immunomodulatory effects ([@b13-etm-0-0-5191],[@b14-etm-0-0-5191]). It has been demonstrated that developing cancer is able to avoid detection and escape the immune response ([@b15-etm-0-0-5191]). By adjusting or stimulating immune functions, the tumor cells may be recognized and targeted by the immune system ([@b16-etm-0-0-5191]). As such, immunotherapy has typically been employed in clinical settings to achieve an improved treatment and outcome of cancer ([@b17-etm-0-0-5191]). Therefore, in the present study, the immunomodulatory effects of PIP were assessed and the potential for PIP to provide antitumor immunotherapy was investigated.

The biological activities of polysaccharides primarily depend on a number of structural features including monosaccharide composition, molecular weight, type of glycosidic bond and branch structures ([@b18-etm-0-0-5191],[@b19-etm-0-0-5191]). For PI, the structure and bioactivity of polysaccharides may be affected by the origin and species. Therefore, in the present study, six different origins or species of PI were collected from China. These PIs were subsequently screened and the one with the best antitumor effect was preliminary studied to assess the antitumor mechanisms. PIP was extracted using a microwave extraction method. The *in vivo* antitumor efficacy, spleen index and thymus index was assessed in Kunming (KM) mice bearing H22 tumors to identify the PI with the highest antitumor efficacy. The antitumor mechanism was investigated using MTT assay and by testing the concentration of serum immune cytokines including interleukin-2 (IL-2), interleukin-12 (IL-12) and interferon-γ (IFN-γ).

Materials and methods
=====================

### Materials

A total of six types of PI fruiting bodies (including Dongbei mulberry *Phellinus igniarius* and Dongbei white birch *Phellinus igniarius*) were obtained from Shandong, Gansu, Hunan, unknown origin and Dongbei province of China. All chemicals and kits were obtained commercially. Cyclophosphamide (CTX) and *Trametes versicolor* polysaccharopeptide (PSP) were purchased from the Jinan Central Hospital (Jinan, China). HepG2 and murine hepatocellular liver carcinoma (H22) cells were obtained from the Shandong Institute of Immunopharmacology and Immunotherapy (Jinan, China). MTT and RPMI-1640 were purchased from Sigma-Aldrich (Merck KGaA; Darmstadt, Germany). IL-2, IL-12 and IFN-γ kits were purchased from Jinan Rebecca Trading Co. (Jinan, China).

### Animals

A total of 140 4-week-old female KM mice with a weight of 18--22 g were supplied by Laboratory Animals Center of Shandong University (Jinan, China). The mice were housed under normal laboratory conditions (24±2°C, 50±20% humidity, 12/12-h light-dark cycle) with free access to standard rodent chow and water. Following acclimatizing to the lighting conditions for 3 days, 132 mice of similar weights were selected for the investigation. The experiment was performed following the guidelines of the Ethical Committee for Animal Experiments of Shandong University. All animal experiments complied with the requirements of the National Act on the Use of Experimental Animals. There were 11 groups in total and 12 mice were used in each group.

### Preparation of PIP

A total of six different types of PI fruiting bodies were dried in an oven at 60°C for 24 h, ground to powdered-form and kept in an air-tight plastic bag at room temperature until use. To prepare crude polysaccharides, 10 g of each PI sample was extracted with 500 ml distilled water using microwave extraction for 15 min, three times. The extract was concentrated with RE52-98 rotary evaporation apparatus (Shanghai Ya Rong Biochemical Instrument Factory, Shanghai, China), precipitated with 80% ethanol and stored at 4°C for 24 h. The method of preparation was as previously described ([@b20-etm-0-0-5191]) and a clear description of the process is demonstrated by the flow diagram presented in [Fig. 1](#f1-etm-0-0-5191){ref-type="fig"}. The concentration of total PIP from Dongbei mulberry, Dongbei birch, Gansu mulberry, Hunan mulberry, Shandong mulberry and mulberry from an un-known place were 5.37, 2.21, 3.04, 3.35, 2.77 and 3.58%, respectively ([@b20-etm-0-0-5191]). The precipitate was subsequently centrifuged at 4°C and 860 × g for 15 min, dried in a vacuum and deproteinized using sevage reagent (chloroform; Shanghai Aladdin Bio-Chem Technology Co., Ltd., Shanghai, China).

### In vivo tumor growth inhibition study

KM mice implanted with H22 cells were used to qualify the relative efficacy of six types of PIP through oral administration. All animal experiments were performed in full compliance with guidelines approved by the Animal Care Committee of Shandong University.

All 132 mice, including the control group, were subcutaneously injected in the right axillary space with 1×10^7^ H22 cells to establish the hepatoma model mice at day 0. Treatments were started 24 h following tumor cell injection.

On Day 0, the mice were randomly divided into 11 groups with 12 mice in each which received the following treatments: Group i) saline; group ii) CTX (intraperitoneal injection; CTX concentration of 25 mg/kg; diluted in saline); group iii): PSP (intragastrically; 200 mg/kg; diluted in distilled water); groups iv-ix): Dongbei mulberry *Phellinus igniarius* polysaccharide (DMPIP), Hunan mulberry *Phellinus igniarius* polysaccharide (HPIP), Gansu mulberry *Phellinus igniarius* polysaccharide (GPIP), Dongbei white birch *Phellinus igniarius* polysaccharide (DWPIP), Shandong mulberry *Phellinus igniarius* polysaccharide (SPIP) and unknown origin *Phellinus igniarius* polysaccharide (UPIP), respectively (intragastrically; 200 mg/kg; diluted in distilled water); group x): GPIP plus CTX at the same time; group xi): PSP plus CTX. The treatments were administered once daily for two weeks. All mice were tagged and tumor size was measured daily with calipers during the period of study. The tumor volume was calculated according to the following formula: (W^2^ × L)/2, where W is the tumor measurement at the widest point and L is the tumor dimension at the longest point. Each mouse was weighed at the time of treatment, so that dosages were adjusted to achieve the correct mg/kg amounts. The body weights of mice were monitored as an index of systemic toxicity. At the end of the experiment, the animals were sacrificed by cervical dislocation, and the tumor, spleen and thymus were harvested by dissection and weighed. The tumor inhibition ratio was calculated according to the following equation: Inhibition rate (%) = (mean tumor weight of saline group-mean tumor weight of treated group)/mean tumor weight of saline group ×100. The thymus and spleen index were calculated using the following formula: Thymus or spleen index = the weight of the thymus or spleen/total weight of mouse.

### Cell culture

HepG2 cells were grown in RPMI-1640 medium containing 10% fetal bovine serum (Sigma-Aldrich; Merck KGaA) for 3 days and then used in the *in vitro* experiment. The cultures were maintained at 37°C under a humidified 5% CO~2~ atmosphere. H22 cells were maintained as ascites in the KM mice by weekly passage.

### In vitro cytotoxic activity

Direct cytotoxicity of GPIP against HepG2 cells was evaluated via MTT assay. Cancer cells were inoculated to 96 well plates at a concentration of 8,000 cells/well and cultured in RPMI-1640 containing 10% serum for 24 h. Following the addition of 25, 50, 100, 250 and 500 µg/ml GPIP, the cancer cells were further incubated for 24, 48 and 72 h respectively. Then 20 µl MTT (5 mg/ml) was added into each well and incubated for a further 4 h. The supernatant was removed carefully and 150 µl dimethyl sulfoxide was added to each well. The absorbance at 490 nm was measured with an ELISA reader. Untreated cells were used as a control with 100% viability and cells without addition of MTT were used as blank to calibrate the spectrophotometer to zero absorbance. The inhibition ratio (IR) was calculated according to the following formula: IR (%) = (1-absorbance of experimental group/absorbance of blank control group) × 100.

### Cytokine measurements

The concentration of serum IL-2, IL-12 and IFN-γ were measured in the normal (non-tumorous, received saline), control, CTX, PSP, GPIP, GPIP + CTX and PSP + CTX groups by a sandwich ELISA method using mouse cytokine ELISA kits (Jinan Rebecca Trading Co.) according to the manufacturer\'s protocol. Assays were performed according to the manufacturer\'s protocol.

### Statistical analysis

Treated and control groups were compared using Student\'s t-test SPSS version 21 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. Results are expressed as means ± standard deviation. P\<0.05 was considered to indicate a statistically significant difference.

Results and Discussion
======================

### Tumor-inhibitory effect of PIP against H22

The *in vivo* antitumor effect of six different types of PIP was assessed via oral administration using KM mice bearing H22 tumors as model animals. The tumor weight and inhibition rate are presented in [Table I](#tI-etm-0-0-5191){ref-type="table"}. Among the PIP groups, only the average tumor weight in the GPIP group decreased significantly vs. the saline group (P\<0.05) and the inhibition rate was 33.71%. Furthermore, the tumor weight in the GPIP group had no significant difference compared with PSP positive control group. The tumor volumes in all groups were measured during the experiment. [Fig. 2A](#f2-etm-0-0-5191){ref-type="fig"} demonstrates the changes in tumor volumes. It was also identified that the tumor volumes in the GPIP group were smaller than those of other PIP groups, together with the tumor weight changes all indicating that the antitumor effect of GPIP was of the most promising among the six different PIP. These results revealed that the antitumor effect was associated with the origin and species. Therefore it was important to study the association between the bioactivity and the origin for better development of PI. Through comparison with other articles, it was identified that PI from different origins had different antitumor activities and the mechanisms were not exactly the same ([@b9-etm-0-0-5191],[@b21-etm-0-0-5191]), which also supported the importance of the present study. Furthermore, in the study from Li *et al* ([@b9-etm-0-0-5191]), proteoglycans with different purity or structures exhibited different antitumor activities. Therefore, it was necessary to initially clarify the association between activity and origin, screen the PIP with the best antitumor effect and then further study the structure, because this may save a lot of material resources, manpower, financial resources and improve the efficiency of scientific research.

[Fig. 2B](#f2-etm-0-0-5191){ref-type="fig"} demonstrates the body weight changes following the 2-week experimental period. The results indicated that, with the exception of the CTX group, the body weight in all PIP groups markedly increased following treatment. The analysis of body weight variations may be used to define the systemic toxicity ([@b22-etm-0-0-5191]). The primary results suggested that PIP was almost non-toxic. CTX, as the chemotherapy drug, served an important role in inhibiting tumor growth, yet its side effects, such as arrest of bone marrow and liver damage, limited its applications. However, the body weight in the two combination groups did not change significantly and thus the results also indicated that GPIP may decrease the toxicity caused by CTX. The safety of PI was the major advantage over conventional chemotherapeutics. The importance of multidisciplinary treatment of cancer in improving patient quality of life has been discussed and the maintenance of quality of life greatly affects decision-making in the therapeutic strategies ([@b23-etm-0-0-5191]).

### Effect of PIP on immunity

The weight of the thymus and spleen reflects the immune functional strength. In the present study, the relative spleen and thymus index are presented in [Table II](#tII-etm-0-0-5191){ref-type="table"}. GPIP significantly increased the spleen index (P\<0.01) of H22-bearing mice compared with the saline and CTX group, whereas CTX significantly decreased thymus index (P\<0.01) compared with the saline group. The spleen index in other PIP groups didn\'t demonstrate any significant increase (P\>0.05) compared with the saline group, which was in accordance with aforementioned antitumor activity. CTX inhibited the growth of tumor, but damaged the immunity of the mice. However, the spleen index in GPIP and CTX combination groups significantly increased compared with CTX group (P\<0.05). The relative spleen and thymus weight were an important index for non-specific immunity. Therefore, these results indicated that GPIP was a potent immunomodulating and immunoenhancing agent, which may enhance the immune function of tumor bearing mice and reduce the immune suppression caused by CTX.

### Antitumor mechanism of GPIP

PI has antitumor effects, but the underlying mechanisms responsible for this phenomenon remained controversial. Li *et al* ([@b11-etm-0-0-5191]) demonstrated that *Phellinus linteus* may inhibit the proliferation of HepG2 cells through inducing S-phase arrest. However, different origins and structure of polysaccharides may result in different antitumor mechanism. To further investigate the antitumor mechanism of GPIP, an MTT assay was performed to demonstrate if the antitumor activity of GPIP was induced by direct cytotoxicity. The results are presented in [Fig. 3](#f3-etm-0-0-5191){ref-type="fig"} and indicate that GPIP exhibited no significant cytotoxicity on HepG2 cells at any concentration or time point. Therefore, the antitumor mechanism of GPIP may not be due to inhibition of tumor proliferation directly.

In view of the aforementioned influence on the immune organs, GPIP may enhance the immune function. Therefore, it was speculated that the antitumor mechanisms of GPIP may be associated with the enhancement of immune function. Macrophages and lymphocytes belong to two major populations of cells in the host defense system, which act against invading pathogens. IFN-γ and IL-2 are secreted by type 1 helper T-cells (Th1 cells) and mediate cellular immunity. IFN-γ performs a tumoricidal activity and induces other cells of the innate immune system, including macrophages and dendritic cells (DCs), to produce IL-12, which further activates cells mediating the innate response ([@b24-etm-0-0-5191]). A number of studies have demonstrated that IFN-γ, IL-12, and IL-2 have a function in the immunomodulation of polysaccharides ([@b3-etm-0-0-5191],[@b4-etm-0-0-5191]) and the determination of cytokine concentration was a simple approach to characterize changes in immune function. Therefore, the serum level of IL-2, IL-12 and IFN-γ was measured in tumor-bearing mice to further demonstrate the antitumor mechanisms of GPIP. The results for the concentration of IL-2, IL-12 and IFN-γ are presented in [Figs. 4](#f4-etm-0-0-5191){ref-type="fig"}--[6](#f6-etm-0-0-5191){ref-type="fig"}, respectively. With GPIP stimulation, the serum levels of the three cytokines significantly increased compared with the saline and CTX groups (P\<0.01). Furthermore, the IL-2 in GPIP group exhibited a significant increase compared with the PSP group (P\<0.05). IL-2 may stimulate the reactivity of numerous types of killer cells, such as natural killer (NK) cells and cytolytic T lymphocytes ([@b21-etm-0-0-5191],[@b25-etm-0-0-5191]), thus the high level of IL-2 enhanced the cytolytic activity of NK cells and cytolytic T lymphocytes. The trend for the secretion of IFN-γ was the same as that observed for the secretion of IL-12. IL-12 is one of the crucial cytokines for transition of the immune response from innate to adaptive as the antigen-presenting cells, such as monocytes and DCs produce a substantial amount of IL-12 that primes the Th1 response ([@b26-etm-0-0-5191]). This in turn induces the production of IFN-γ and IL-12 by the Th1 cells to further stimulate downstream cell-mediated immunity ([@b27-etm-0-0-5191]), which may explain the consistency of IL-12 and IFN-γ in the present study. Furthermore, the three cytokines in GPIP and CTX combination groups also exhibited a significant increase (P\<0.01) compared with CTX, which decreased the level of all these cytokines significantly (P\<0.01). The results indicated that GPIP was not only an immune enhancing agent but also may decrease the immunosuppression caused by CTX. According to these results, GPIP was an effective immunopotentiator and the antitumor mechanism may be associated with the enhancement of immune function, which was regulated by GPIP. In conclusion, GPIP was a promising plant polysaccharide as an immunoregulator that demonstrated great potential in the treatment of cancer.

Hepatocellular carcinoma is one of the most prevalent malignant tumors worldwide, and has an extremely poor prognosis. The results of the present study suggest that PIP may have potential therapeutic applications in a clinical setting. Such immune regulatory effects of PIP should be further investigated to identify how the components of the PIP interact with immune cells.

The present study was supported by the Development of Science and Technology Plan Project of Shandong Province (grant no. 2012GSF1191), Jinan Science and Technology Project (grant no. 201101025).

![Flow chart of extraction for *Phellinus igniarius* polysaccharides.](etm-14-05-4627-g00){#f1-etm-0-0-5191}

![*In vivo* antitumor effect of PIP. (A) Tumor volume changes in different groups; (B) body weight changes of the mice. \*P\<0.05, \*\*P\<0.01 vs. weight before the experiment. PIP, *Phellinus igniarius* polysaccharides; CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; DMPIP, Dongbei mulberry PIP; HPIP, Hunan mulberry PIP; GPIP, Gansu mulberry PIP; DWPIP, Dongbei white birch PIP; SPIP, Shandong mulberry PIP; UPIP, unknown origin PIP.](etm-14-05-4627-g01){#f2-etm-0-0-5191}

![Cytoxicity of GPIP on HepG2 cells. Cells were treated with various concentrations of GPIP (25, 50, 100, 250 and 500 µg/ml) for 24, 48 and 72 h, (n=3). GPIP, Gansu *Phellinus igniarius* polysaccharides.](etm-14-05-4627-g02){#f3-etm-0-0-5191}

![Serum IL-2 in H22-bearing mice. H22-bearing mice were administered saline (negative control group), saline (normal group, non-tumorous), CTX, PSP, GPIP, GPIP + CTX and PSP + CTX once daily, for 14 days. Sera were collected from the tumor-bearing mice on day 15. IL-2 concentration was determined using ELISA method (n=3). \*P\<0.01 vs. saline group, ^\#^P\<0.01 vs. CTX group, and ^∆^P\<0.05 vs. PSP group. IL-2, interleukin-2; CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; GPIP, Gansu mulberry *Phellinus igniarius* polysaccharides; ELISA, enzyme-linked immunosorbent assay.](etm-14-05-4627-g03){#f4-etm-0-0-5191}

![Serum IL-12 in H22-bearing mice. H22-bearing mice were administered saline (negative control group), saline (normal group, non-tumorous), CTX, PSP, GPIP, GPIP + CTX and PSP + CTX once daily, for 14 days. Sera were collected from the tumor bearing mice on day 15. IL-12 concentration was determined using ELISA method (n=3). \*P\<0.01 vs. saline group, ^\#^P\<0.01 vs. CTX group. IL-12, interleukin-12; CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; GPIP, Gansu mulberry *Phellinus igniarius* polysaccharides; ELISA, enzyme-linked immunosorbent assay.](etm-14-05-4627-g04){#f5-etm-0-0-5191}

![Serum IFN-γ in H22-bearing mice. H22-bearing mice were administered saline (negative control group), saline (normal group, non-tumorous), CTX, PSP, GPIP, GPIP + CTX and PSP + CTX once daily, for 14 days. Sera were collected from the tumor bearing mice on day 15. IFN-γ concentration was determined using ELISA method (n=3). \*P\<0.01 vs. saline group, ^\#^P\<0.01 vs. CTX group. IFN-γ, interferon-γ; CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; GPIP, Gansu mulberry *Phellinus igniarius* polysaccharides; ELISA, enzyme-linked immunosorbent assay.](etm-14-05-4627-g05){#f6-etm-0-0-5191}

###### 

Effect of PIP on the number of living mice, tumor weight and inhibitory rate of H22 cells.

             Total no. of mice                                                                    
  ---------- ------------------- ---- ----------------------------------------------------------- --------
  Saline     12                  12   0.798±0.214                                                 
  CTX        12                  10   0.234±0.050^[b](#tfn2-etm-0-0-5191){ref-type="table-fn"}^   70.68
  PSP        12                  12   0.493±0.230^[a](#tfn1-etm-0-0-5191){ref-type="table-fn"}^   38.22
  DMPIP      12                  11   0.624±0.300                                                 21.80
  HPIP       12                  11   0.602±0.276                                                 24.56
  GPIP       12                  12   0.529±0.240^[a](#tfn1-etm-0-0-5191){ref-type="table-fn"}^   33.71
  DWPIP      12                  12   0.601±0.298                                                 24.69
  SPIP       12                  11   0.576±0.270                                                 27.57
  UPIP       12                  11   0.800±0.370                                                   0.00
  GPIP+CTX   12                  12   0.262±0.104^[b](#tfn2-etm-0-0-5191){ref-type="table-fn"}^   67.11
  PSP+CTX    12                  12   0.294±0.069^[b](#tfn2-etm-0-0-5191){ref-type="table-fn"}^   63.11

P\<0.05

P\<0.01 vs. saline group. H22-bearing mice were orally administered saline, CTX 25 mg/kg (intraperitoneal administration, positive control), PSP 200 mg/kg (positive control) and all types of PIP 200 mg/kg once daily, for 14 days. Each value is presented as mean ± standard deviation, n=12. PIP, *Phellinus igniarius* polysaccharides; CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; DMPIP, Dongbei mulberry PIP; HPIP, Hunan mulberry PIP; GPIP, Gansu mulberry PIP; DWPIP, Dongbei white birch PIP; SPIP, Shandong mulberry PIP; UPIP, unknown origin PIP.

###### 

Immune organ indexes in H22-bearing mice (n=12).

  Groups     Thymus indexes mg/10 g                                     Spleen indexes mg/10 g
  ---------- ---------------------------------------------------------- -------------------------------------------------------------------------------------------------------
  Control    29.19±6.22                                                 44.42±5.63
  CTX        13.69±5.52^[b](#tfn4-etm-0-0-5191){ref-type="table-fn"}^   41.97±9.40
  PSP        31.28±4.68^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   54.71±4.34^[a](#tfn3-etm-0-0-5191){ref-type="table-fn"},[c](#tfn5-etm-0-0-5191){ref-type="table-fn"}^
  DMPIP      19.84±5.33^[a](#tfn3-etm-0-0-5191){ref-type="table-fn"}^   54.66±9.53
  HPIP       23.14±2.12^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   52.52±7.43
  GPIP       30.97±5.45^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   63.40±8.15^[b](#tfn4-etm-0-0-5191){ref-type="table-fn"},[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^
  DWPIP      25.68±5.69^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   43.12±12.89
  SPIP       28.84±5.90^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   51.26±8.77
  UPIP       26.59±5.24^[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^   48.03±9.72
  GPIP+CTX   17.63±5.01^[b](#tfn4-etm-0-0-5191){ref-type="table-fn"}^   61.99±9.07^[b](#tfn4-etm-0-0-5191){ref-type="table-fn"},[d](#tfn6-etm-0-0-5191){ref-type="table-fn"}^
  PSP+CTX    20.28±6.79^[a](#tfn3-etm-0-0-5191){ref-type="table-fn"}^   56.30±9.00^[a](#tfn3-etm-0-0-5191){ref-type="table-fn"},[c](#tfn5-etm-0-0-5191){ref-type="table-fn"}^

P\<0.05

P\<0.01 vs. saline group

P\<0.05

P\<0.01 vs. CTX group. CTX, cyclophosphamide; PSP, *Trametes versicolor* polysaccharopeptide; PIP, *Phellinus igniarius* polysaccharides; DMPIP, Dongbei mulberry PIP; HPIP, Hunan mulberry PIP; GPIP, Gansu mulberry PIP; DWPIP, Dongbei white birch PIP; SPIP, Shandong mulberry PIP; UPIP, unknown origin PIP.
